Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if fluticasone 500mcg/salmeterol 50mcg can improve the
survival of subjects with COPD and also assess the long term safety profile of this drug.